155 related articles for article (PubMed ID: 38431566)
1. Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer.
Wang Y; Ouyang S; Liu M; Si Q; Zhang X; Zhang X; Li J; Wang P; Ye H; Shi J; Song C; Wang K; Dai L
BMC Cancer; 2024 Mar; 24(1):283. PubMed ID: 38431566
[TBL] [Abstract][Full Text] [Related]
2. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
Front Immunol; 2021; 12():728853. PubMed ID: 35140701
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer.
Wang Y; Li J; Zhang X; Liu M; Ji L; Yang T; Wang K; Song C; Wang P; Ye H; Shi J; Dai L
Clin Immunol; 2023 Jan; 246():109206. PubMed ID: 36528251
[TBL] [Abstract][Full Text] [Related]
4. Ubiquilin proteins regulate EGFR levels and activity in lung adenocarcinoma cells.
Kurlawala Z; Saurabh K; Dunaway R; Shah PP; Siskind LJ; Beverly LJ
J Cell Biochem; 2021 Jan; 122(1):43-52. PubMed ID: 32720736
[TBL] [Abstract][Full Text] [Related]
5. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.
Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L
Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response to epidermal growth factor receptor in lung cancer.
Wang Y; Liu F; OuYang S; Liu M; Zhang X; Wang P; Zhao C; Zhang L; Dai L
Immunol Res; 2021 Feb; 69(1):71-80. PubMed ID: 33495907
[TBL] [Abstract][Full Text] [Related]
7. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
[No Abstract] [Full Text] [Related]
8. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
[TBL] [Abstract][Full Text] [Related]
9. Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma
Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
PeerJ; 2024; 12():e17141. PubMed ID: 38529301
[TBL] [Abstract][Full Text] [Related]
10. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
11. Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis.
Shah PP; Saurabh K; Kurlawala Z; Vega AA; Siskind LJ; Beverly LJ
Neoplasia; 2022 Mar; 25():1-8. PubMed ID: 35063704
[TBL] [Abstract][Full Text] [Related]
12. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
14. Clinical value of serum DJ-1 in lung adenocarcinoma.
Wang L; Wei L; Miao S; Zhang W
PeerJ; 2024; 12():e16845. PubMed ID: 38304191
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of ubiquilin 1 in gastric cancer.
Bao J; Jiang X; Zhu X; Dai G; Dou R; Liu X; Sheng H; Liang Z; Yu H
Medicine (Baltimore); 2018 Jan; 97(3):e9701. PubMed ID: 29505024
[TBL] [Abstract][Full Text] [Related]
16. Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer.
Sun N; Chen Z; Tan F; Zhang B; Yao R; Zhou C; Li J; Gao Y; Liu Z; Tan X; Zhou F; He MY; Shao K; Li N; Qiu B; Sun J; Yu Y; Wang S; Zhao Y; Shi X; He J
Clin Cancer Res; 2013 Sep; 19(18):5136-45. PubMed ID: 24046070
[TBL] [Abstract][Full Text] [Related]
17. Combination of serum ACSL4 levels and low-dose 256-slice spiral CT exhibits the potential in the early screening of lung cancer.
Yu W; Wang L; Liu S; Liu Y; Wang S; Sun X
Medicine (Baltimore); 2023 Feb; 102(5):e32733. PubMed ID: 36749237
[TBL] [Abstract][Full Text] [Related]
18. Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules.
Zhang X; Ji L; Liu M; Li J; Sun H; Liang F; Zhao Y; Wang Z; Yang T; Wang Y; Si Q; Du R; Dai L; Ouyang S
J Proteome Res; 2024 Jan; 23(1):277-288. PubMed ID: 38085828
[TBL] [Abstract][Full Text] [Related]
19. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
20. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma.
Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L
BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
